Empresa DanDrit Biotech USA Inc OTC Bulletin Board
Acciones
US2360781015
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 23/01/18 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 21/08/23 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/16 |
Joseph R. Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
François Binette
COO | Chief Operating Officer | - | 20/04/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 01/01/20 |
Avram Miller
BRD | Director/Board Member | - | 11/10/23 |
James Sapirstein
BRD | Director/Board Member | 63 | 06/03/18 |
Director/Board Member | 60 | 04/10/23 | |
Director/Board Member | 78 | 04/10/23 | |
Carol Brosgart
BRD | Director/Board Member | 72 | 27/12/19 |
Rene Sindlev
CHM | Chairman | 61 | 18/01/11 |
Mark Dybul
CEO | Chief Executive Officer | 60 | 23/01/18 |
Jayne McNicol
BRD | Director/Board Member | 57 | 25/05/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 147 504 944 | 109 814 931 ( 74,45 %) | 0 | 74,45 % |
Acción B | 0 | 561 010 | 0 | 0 |
Información de la empresa
Renovaro, Inc.
1927 Paseo Rancho Castillo
90032-2012, Los Angeles
+45 39 17 98 40
http://www.enochianbio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,42 % | 115 mil M | |
+11,84 % | 106 mil M | |
-1,05 % | 21,96 mil M | |
-14,15 % | 21,87 mil M | |
-5,29 % | 19,21 mil M | |
-4,16 % | 18,08 mil M | |
-38,29 % | 17,71 mil M | |
+7,99 % | 14,32 mil M | |
+36,24 % | 12,42 mil M |
- Bolsa de valores
- Acciones
- Acción RENB
- Acción
- Empresa DanDrit Biotech USA Inc